Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gross and cytological appearance of oral gout in a crested gecko (Correlophus ciliatus) with end-stage nephropathy.

The Journal of small animal practice·2026
Same author

Four Cases of the Melanotic Variant of Malignant Nerve Sheath Tumour: a Rare, Aggressive Neoplasm in Young Dogs with a Predilection for the Spinal Cord.

Journal of comparative pathology·2020
Same author

Intracerebral Astrocytoma in a Horse.

Journal of comparative pathology·2020
Same author

Immunohistochemical Characterization of Immune Cell Infiltration in Feline Glioma.

Journal of comparative pathology·2018
Same author

Neuroendodermal cyst in the fourth ventricle of a dog.

Australian veterinary journal·2017
Same author

Surgical removal of a choroid plexus oncocytoma in an adult cat.

The Journal of small animal practice·2017

Related Experiment Video

Updated: Jul 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Cationic liposome systems in gene therapy.

A D Miller1

  • 1Imperial College of Science, Technology & Medicine, Department of Chemistry, South Kensington, London, SW7 2AY, UK. a.miller@ic.ac.uk

Idrugs : the Investigational Drugs Journal
|May 10, 2008
PubMed
Summary

Cationic liposomes show promise for gene therapy delivery in patients. However, significant technical challenges remain for their widespread use as gene delivery vehicles in clinical applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Cationic liposomes are established agents for facilitating nucleic acid delivery to cells in laboratory settings.
  • Gene therapy offers a potential treatment modality for various diseases by delivering therapeutic genes or nucleic acids.

Purpose of the Study:

  • To evaluate the feasibility and current limitations of using cationic liposomes as vectors for in vivo gene therapy.
  • To assess the potential of cationic liposome systems for future clinical gene therapy applications.

Main Methods:

  • Review of existing literature on cationic liposome-mediated nucleic acid delivery in vitro and in vivo.
  • Analysis of technical challenges and research progress in the field of gene therapy vectors.

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Related Experiment Videos

Last Updated: Jul 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Main Results:

  • Cationic liposomes have demonstrated efficacy in delivering nucleic acids in vivo for gene therapy research.
  • Numerous technical problems persist, hindering the direct clinical translation of this technology.

Conclusions:

  • While cationic liposomes hold potential as gene therapy vectors, substantial advancements in basic research are required.
  • Further development is essential to overcome current obstacles and realize the future clinical utility of cationic liposomes in gene therapy.